FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:1689-1690 June 4, 1998 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Pablos-Méndez, A. PubMed Citation

In this issue of the Journal, Pablos-Méndez et al., on behalf of the World Health Organization–International Union against Tuberculosis and Lung Diseases Working Group on Anti-Tuberculosis Drug Resistance Surveillance, report data on drug resistance in 35 countries or regions.¹ Among patients with no history of prior treatment, a median of 9.9 percent (range, 2 to 41 percent) of Mycobacterium tuberculosis strains were resistant to at least one drug. Among patients with histories of prior treatment for more than one month, the prevalence of resistance to any drug ranged from 5.3 to 100 percent, and the prevalence of multidrug resistance (defined . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Shah, N. S., Pratt, R., Armstrong, L., Robison, V., Castro, K. G., Cegielski, J. P. (2008). Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007. JAMA 300: 2153-2160 [Abstract] [Full Text]  
• Marra, F., Marra, C. A., Moadebi, S., Shi, P., Elwood, R. K., Stark, G., FitzGerald, J. M. (2005). Levofloxacin Treatment of Active Tuberculosis and the Risk of Adverse Events. Chest 128: 1406-1413 [Abstract] [Full Text]  
• Sinha, S., Kosalai, K., Arora, S., Namane, A., Sharma, P., Gaikwad, A. N., Brodin, P., Cole, S. T. (2005). Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. Microbiology 151: 2411-2419 [Abstract] [Full Text]  
• Loddenkemper, R., Sagebiel, D., Brendel, A. (2002). Strategies against multidrug-resistant tuberculosis. Eur Respir J 20: 66S-77s [Abstract] [Full Text]  
• Narita, M., Alonso, P., Lauzardo, M., Hollender, E. S., Pitchenik, A. E., Ashkin, D. (2001). Treatment Experience of Multidrug-Resistant Tuberculosis in Florida, 1994-1997. Chest 120: 343-348 [Abstract] [Full Text]  
• Brooks, J. V., Frank, A. A., Keen, M. A., Bellisle, J. T., Orme, I. M. (2001). Boosting Vaccine for Tuberculosis. Infect. Immun. 69: 2714-2717 [Abstract] [Full Text]